Pharmaceutical Development and Technology

Papers
(The H4-Index of Pharmaceutical Development and Technology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Insights into tablet sticking: a quantitative case study with an ibuprofen and methocarbamol-based formulation98
Facile fabrication of degradable, serrated polyethylene diacrylate microneedles using stereolithography44
Influence of punch coating surface properties on sticking during the tableting process44
Formulation and characterization of a fixed-dose microemulsion containing efavirenz, emtricitabine, and tenofovir26
Formulation and optimization of a single-layer coat for targeting budesonide pellets to the descending Colon24
Novel vanillic acid-loaded in situ gels: development, characterization, in vitro evaluation for enhanced wound healing and skin irritation24
Gum tragacanth-based hemostatic sponge for enhanced hemostasis in dental surgery21
Glycyrrhizic acid assists anti-psoriatic efficacy of a self-deformable curcumin loaded transdermal gel20
Development of PLGA-SPC3 functionalized gefitinib mesoporous silica nano-scaffolds for breast cancer targeting: biodistribution and cytotoxicity analysis20
Cationic Okra gum coated nanoliposomes as a pH-sensitive carrier for co-delivery of hesperetin and oxaliplatin in colorectal cancers17
Scale-up in twin-screw wet granulation: impact of formulation properties16
Comparison study of physicochemical and biopharmaceutics properties of hydrophobic drugs ground by two dry milling processes16
Emulgels: a promising topical drug delivery system for arthritis management and care15
Preparation, characterization, and antibacterial activity of tigecycline-loaded, ultrasound-activated microbubbles15
An innovative carrier for the formulation of amorphous solid dispersion by hot-melt extrusion with no further downstream processes: a case study with indomethacin.15
0.075448989868164